HHealth Read More Singapore becomes first APAC market to approve MSD’s Enflonsia for infant RSV preventionJune 2, 2026 Singapore becomes first APAC market to approve MSD’s Enflonsia for infant RSV prevention June 2, 2026 | Tuesday…